Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Healthcare Triangle (HCTI) EBIAT (2020 - 2025)

Healthcare Triangle filings provide 6 years of EBIAT readings, the most recent being $14.8 million for Q4 2025.

  • On a quarterly basis, EBIAT rose 57.51% to $14.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.8 million, a 106.02% increase, with the full-year FY2025 number at $9.8 million, up 106.04% from a year prior.
  • EBIAT reached $14.8 million in Q4 2025 per HCTI's latest filing, up from -$1.9 million in the prior quarter.
  • The five-year high for EBIAT was $14.8 million in Q4 2025, with the low at -$3.3 million in Q4 2021.
  • A 5-year average of -$55900.0 and a median of -$1.7 million in 2023 define the central range for EBIAT.
  • Year-over-year, EBIAT crashed 1375.13% in 2021 and then surged 658.19% in 2024.
  • Year by year, EBIAT stood at -$3.3 million in 2021, then surged by 227.01% to $4.2 million in 2022, then plummeted by 139.59% to -$1.7 million in 2023, then surged by 658.19% to $9.4 million in 2024, then skyrocketed by 57.51% to $14.8 million in 2025.
  • Per Business Quant, the three most recent readings for HCTI's EBIAT are $14.8 million (Q4 2025), -$1.9 million (Q3 2025), and -$1.4 million (Q2 2025).